Translational experimental research in gynaecological oncology.

For example, haematology and urology departments often have oncology research laboratories, and the trade associations organise support, e.g. in the form of research grants and experimental oncology meetings. To the Editor, The aim in modern gynaecological oncology is individualised treatment. A current example is the PIK3CA specific inhibitor alpelisib, which enables targeted therapy in routine breast cancer treatment (Hofmann et al. [1]; Shah et al. [6]; Jain et al. [2]). [Extracted from the article]